Literature DB >> 18719376

p53 Binding to the p21 promoter is dependent on the nature of DNA damage.

Richard Hill1, Ewelina Bodzak, Michael D Blough, Patrick W K Lee.   

Abstract

p53 Is a tumor suppressor that integrates signals from different stress induced signalling pathways, regulates cell cycle arrest, senescence, apoptosis and DNA repair. How p53 dictates cell fate is unclear. As a major transcriptional target of p53 in response to cellular stress, p21 is a key component in cell cycle control and apoptosis, directing an anti-apoptotic response following DNA damage. It is therefore likely that p53-dependent regulation of p21 contributes, at least in part, how p53 influences cellular outcome upon DNA damage. Here we compare the p53-dependent transcriptional regulation of p21 in response to DNA damage by ultraviolet (UV) radiation and ionizing radiation (IR). We demonstrate that despite comparable levels of p53 accumulation by both types of DNA damage, IR causes significant, early accumulation of p21 not seen in UV-damaged cells, with a substantially different cell cycle profile. Whereas UV and IR both target p21 protein for degradation immediately after DNA damage, differential post-damage p21 transcription is accountable for the disparity in p21 protein levels. Chromatin immunoprecipitation studies reveal that p53 displays a clear bias against the p21 promoter in UV-damaged cells compared to IR-damaged cells. We note differential post-translational modifications of nuclear p53 between UV and IR treatment. Furthermore we demonstrate that this disparity correlated with reduced histone acetylation on the TATA box within the p21 promoter following UV treatment. This suggests that the nature of DNA damage enables p53 to selectively discriminate between promoters in the induction of target genes, thereby regulating their expression and subsequent cellular outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719376     DOI: 10.4161/cc.7.16.6440

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization.

Authors:  Daniel K Fox; Scott M Ebert; Kale S Bongers; Michael C Dyle; Steven A Bullard; Jason M Dierdorff; Steven D Kunkel; Christopher M Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-03       Impact factor: 4.310

2.  Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.

Authors:  Priyatham Gorjala; Ronald K Gary
Journal:  Biometals       Date:  2010-06-12       Impact factor: 2.949

3.  Human bone marrow stromal cells display variable anatomic site-dependent response and recovery from irradiation.

Authors:  Monika Damek-Poprawa; Derek Stefanik; Lawrence M Levin; Sunday O Akintoye
Journal:  Arch Oral Biol       Date:  2010-04-07       Impact factor: 2.633

4.  Functional p53 determines docetaxel sensitivity in prostate cancer cells.

Authors:  Chengfei Liu; Yezi Zhu; Wei Lou; Nagalakshmi Nadiminty; Xinbin Chen; Qinghua Zhou; Xu Bao Shi; Ralph W deVere White; Allen C Gao
Journal:  Prostate       Date:  2012-09-19       Impact factor: 4.104

5.  Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.

Authors:  Jeremy S Schaefer; Yamini Sabherwal; Heidi Y Shi; Venkataraman Sriraman; JoAnne Richards; Alex Minella; David P Turner; Dennis K Watson; Ming Zhang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

6.  Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.

Authors:  Raoul Frijters; Wilco Fleuren; Erik J M Toonen; Jan P Tuckermann; Holger M Reichardt; Hans van der Maaden; Andrea van Elsas; Marie-Jose van Lierop; Wim Dokter; Jacob de Vlieg; Wynand Alkema
Journal:  BMC Genomics       Date:  2010-06-05       Impact factor: 3.969

7.  Ototoxicity from combined Cisplatin and radiation treatment: an in vitro study.

Authors:  Wong-Kein Low; Sylvia W W Kong; Michelle G K Tan
Journal:  Int J Otolaryngol       Date:  2010-12-01

8.  HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.

Authors:  Jessica A Bertout; Amar J Majmundar; John D Gordan; Jennifer C Lam; Dara Ditsworth; Brian Keith; Eric J Brown; Katherine L Nathanson; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

9.  Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.

Authors:  Eun-Woo Lee; Min-Sik Lee; Suzanne Camus; Jaewang Ghim; Mi-Ran Yang; Wonkyung Oh; Nam-Chul Ha; David P Lane; Jaewhan Song
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

10.  Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells.

Authors:  Zhongwei Liu; Weimin Gao
Journal:  Arch Toxicol       Date:  2020-06-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.